Bericht

COVID-19 vaccines as global public goods: Between life and profit

In the context of a health emergency like the COVID-19 pandemic, the global availability of and access to vaccines are imperative. This research paper provides an analysis from the perspective of international political economy, of the financing of COVID-19 vaccines and of the market strategies adopted by some of the companies that developed them. It notes that the development of vaccines was supported by substantial public funding from countries that later received preferential access to those vaccines through advance purchases. Despite such public support, the vaccines were not deemed as public goods but remained under the control of their developers.

Sprache
Englisch

Erschienen in
Series: Research Paper ; No. 154

Klassifikation
Sozialwissenschaften, Soziologie, Anthropologie
Thema
Access to Vaccines
Advance Purchases
COVID-19
Global Common Goods
Global Health
Global Public Good
Global South
Health
Intellectual Property
Pandemic
Patent
Public Health
Vaccine Financing
Vaccines

Ereignis
Geistige Schöpfung
(wer)
King Mantilla, Katiuska
Carranza Barona, César
Ereignis
Veröffentlichung
(wer)
South Centre
(wo)
Geneva
(wann)
2022

Handle
Letzte Aktualisierung
10.03.2025, 11:44 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Bericht

Beteiligte

  • King Mantilla, Katiuska
  • Carranza Barona, César
  • South Centre

Entstanden

  • 2022

Ähnliche Objekte (12)